From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Tennessee Gov. Bill Lee made waves in early 2023, when he rejected millions of dollars in federal HIV prevention programming.

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Op-ed: By investing in a peer workforce, policymakers can help Latinx communities overcome barriers to accessing quality HIV ...

Data reinforce that twice-yearly lenacapavir could be a highly effective and potentially game-changing HIV prevention option. The double-blind, multicenter, randomized study phase III study ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...